Non-ionizing light-based low-level laser therapy has been used to treat lymphedema in breast cancer patients. Photons of a predetermined frequency (650 nm and 1000 nm) enter skin tissue during laser treatment or photograph biomodulation treatment in order to deliver low beams and dosages to the targeted location. Tissue hardness reduction, lymphatic ease, redness, and lymph vessel recovery have all benefited from its use. However, LLLT relies on cellular biochemical changes as its primary instrument. During the course of the treatment, lymphocytes, smooth cells, fibroblasts, and osteoblasts undergo complete reprogramming. These effects happen as a result of quick reactions that also keep certain light frequencies the same. During high doses of chemotherapy, radiation therapy, or chemical treatment, a woman may experience negative side effects such as extreme hunger, vomiting, spitting, weakness, and balding.
HTML PDFShare this article
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
